Related Experiment Video
Updated: May 6, 2026

12:21
Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging
Published on: September 12, 2011
24.5K
Current progress and challenges in the search for autism biomarkers
Irina Voineagu1, Hee Jeong Yoo
1School of Biotechnology and Biomolecular Sciences, University of New South Wales, Kensington, Sydney, NSW 2052, Australia.
Disease Markers
|October 30, 2013
Summary
Researchers are identifying biological markers for autism spectrum disorder (ASD) to improve early diagnosis. This review discusses progress, challenges, and ethical considerations for clinical application of ASD biomarkers.
Area of Science:
- Neurodevelopmental disorders
- Biomarker discovery
- Clinical diagnostics
Background:
- Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with significant clinical and etiological heterogeneity.
- Current ASD diagnosis relies solely on behavioral assessments, highlighting the need for objective biological markers.
- Identifying reliable biomarkers is crucial for advancing risk prediction and early detection of ASD.
Purpose of the Study:
- To review recent advancements in the identification of biological markers for autism spectrum disorder.
- To discuss the challenges associated with translating ASD biomarker research into clinical practice.
- To explore the ethical considerations pertinent to the clinical implementation of ASD biomarkers.
Main Methods:
- Literature review of recent studies on ASD biomarker research.
- Analysis of progress in identifying potential biological markers for ASD.
- Discussion of challenges in clinical translation and ethical implications.
Main Results:
- Significant research efforts are underway to discover biological markers for ASD.
- Progress has been made, but challenges remain in validating and implementing these markers.
- Ethical considerations are paramount for the responsible translation of biomarker research.
Conclusions:
- Identifying biological markers for ASD is a critical area of ongoing research.
- Overcoming translational and ethical hurdles is essential for clinical utility.
- Future efforts should focus on robust validation and responsible integration into diagnostic pathways.

